NC-6004: Clinical Trials

3 trials of NC-6004, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 22Completed 2

Follow NC-6004: new trials by email Literature Review of NC-6004 trials Research Report on NC-6004

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NC-6004, Cetuximab, 5-FU - Carcinoma, Squamous Cell of Head and Neck
Phase 1 / Phase 2CompletedNanoCarrier Co., Ltd.12017-03-012019-04-29
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
NC-6004, Cetuximab, 5-FU - Head and Neck Neoplasms
Phase 1TerminatedOrient Europharma Co., Ltd.42016-06-012021-04-30
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
NC-6004, Gemcitabine - Solid Tumors
Phase 1 / Phase 2CompletedNanoCarrier Co., Ltd.1192014-05-012025-01-22

Conditions studied

Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

NanoCarrier Co., Ltd. (2)  ·  Orient Europharma Co., Ltd. (1)

Countries

Bulgaria (2)  ·  Romania (2)  ·  United States (2)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Taiwan (1)

Top investigators

Atsushi Osada, Study Director (1)  ·  Joao da Silva, MD (1)  ·  Ruey-Long Hong, MD PhD (1)